Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2016 Dec;117(6):680–689.e1. doi: 10.1016/j.anai.2016.10.014

Table 4.

Inferred HLA allele restriction analysis performed using the RATE analysis tool. A- Allele, R- Responder, RF- relative frequency, OR-odds ratio. P<0.05 is considered significant.

Number of donors Percentage of of donors
Antigen Start Peptide Allele(s) of inferred restriction A+R+ A−
R+
A+R− A−
R−
A+R+ A−
R+
A+R− A−
R−
No. of
donors
RF OR p-
value
Cry j 1 233 SMKVTVAFNQFGPNCG DPB1*05:01,DRB5*01:01,DRB1*04:01 9 0 7 16 28% 0% 22% 50% 32 2.0 inf 0.001
Cry j 2 121 DGIIAAYQNPASWKNN DRB1*15:02,DRB5*01:01,DRB5*01:02,DRB5*02:02 8 2 3 19 25% 6% 9% 59% 32 2.3 25.3 0.001
Cry j 2 113 QPHFTFKVDGIIAAYQ DPB1*02:01,DPB1*09:01,DRB1*15:02,DPB1*01:01 7 0 8 17 22% 0% 25% 53% 32 2.1 inf 0.002
Cry j 2 393 IKLSDISLKLTSGKIA DPB1*02:01,DRB1*15:02,DRB5*01:02 6 0 6 20 19% 0% 19% 63% 32 2.7 inf 0.001
Cry j 2 217 VKIIGISITAPRDSPN DRB1*15:02,DRB1*04:03,DRB5*01:01,DRB5*01:02,DRB1*14:01 6 1 5 20 19% 3% 16% 63% 32 2.5 24.0 0.003
Cry j 2 401 KLTSGKIASCLNDNAN DRB1*04:04,DQB1*03:03,DRB1*15:02,DRB1*04:01 5 1 4 22 16% 3% 13% 69% 32 3.0 27.5 0.003
Cry j 2 129 NPASWKNNRIWLQFAK DRB1*15:01,DPB1*18:01,DPB1*11:01,DRB1*15:02 5 1 4 22 16% 3% 13% 69% 32 3.0 27.5 0.003
Cry j 2 89 PSAMLLVPGSKKFVVN DRB1*13:03,DRB1*15:02,DRB1*03:02,DRB5*01:02 5 1 1 25 16% 3% 3% 78% 32 4.4 125.0 0.000
Cry j 1 321 QDVFYNGAYFVSSGKY DPB1*18:01,DPB1*11:01,DPB1*05:01,DRB3*01:01 5 0 6 21 16% 0% 19% 66% 32 2.9 inf 0.002
Cry j 2 137 RIWLQFAKLTGFTLMG DPB1*18:01,DPB1*11:01,DRB1*15:02,DRB5*01:02,DPB1*09:01,DPB1*03:01 5 2 2 23 16% 6% 6% 72% 32 3.3 28.8 0.002
Cry j 1 281 TILSEGNSFTAPNESY DRB1*04:05,DRB1*15:02,DRB1*04:01 5 1 4 22 16% 3% 13% 69% 32 3.0 27.5 0.003
Cry j 1 129 VFIKRVSNVIIHGLYL DRB1*14:04,DRB1*04:04,DRB1*15:02,DRB5*01:02 5 3 1 23 16% 9% 3% 72% 32 3.3 38.3 0.002
Cry j
IFR
121 AVEPMKSMFDLKIKLR DRB1*16:02,DRB5*02:02,DRB1*13:01,DRB1*03:01 4 0 2 26 13% 0% 6% 81% 32 5.3 inf 0.000
Cry j 2 81 AWQAACKNPSAMLLVP DRB1*15:02,DRB1*13:03,DRB1*03:01 4 0 5 23 13% 0% 16% 72% 32 3.6 inf 0.004
Cry j 1 257 GLVHVANNNYDPWTIY DRB1*04:05,DRB1*15:02,DQB1*05:03 4 0 5 23 13% 0% 16% 72% 32 3.6 inf 0.004
Cry j 1 353 GNATPQLTKNAGVLTC DRB3*03:01,DRB1*15:02,DRB1*13:03,DRB1*13:02 4 4 2 22 13% 13% 6% 69% 32 2.7 11.0 0.023
Cry j 1 89 LWIIFSGNMNIKLKMP DPB1*11:01,DRB1*15:02,DPB1*09:01,DRB1*04:03,DRB5*01:02,DRB1*14:01 4 2 1 25 13% 6% 3% 78% 32 4.3 50.0 0.002
Cry j 2 361 QIQDVTYKNIRGTSAT DRB1*15:01,DRB1*15:02,DRB5*01:02,DRB1*04:01 4 0 6 22 13% 0% 19% 69% 32 3.2 inf 0.006
Cry j 1 209 SNNLFFNHHKVMLLGH DRB1*08:01,DRB1*04:01,DRB1*03:01 4 1 3 24 13% 3% 9% 75% 32 3.7 32.0 0.004
Cry j 1 313 SNWVWQSTQDVFYNGA DRB1*09:01,DRB1*15:02,DRB1*04:01,DPB1*09:01 4 0 5 23 13% 0% 16% 72% 32 3.6 inf 0.004